LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Automated Device Designed for Blood Group Serology

By LabMedica International staff writers
Posted on 21 Jul 2010
Routine blood typing and other interrelated tests can be performed on a fully automated, high-throughput system. The instrument is adaptable for any immunohematology procedure and easily connected to the host system, with compliant software and intelligent robotics.

The flexible system allows the operator to perform the following tests: blood grouping, reverse grouping, phenotyping, crossmatching, antibody screening, antibody identification, and direct antiglobulin tests.

The IH-1000 system has the capacity to stock reagent supplies of 240 ID-Cards, 28 vials of test cells and diluents as required. The instrument processes without restocking of reagents for an average of six to nine hours, depending on the test profile chosen. The appliance automatically shows the level of the reagent supplies and additional reagents can be introduced at any time. The status of the supplies is checked by the device itself or from a remote location, for example from a Wi-Fi connection.

Bio-Rad Laboratories, Inc., (Hercules, CA, USA) manufactures the IH-1000 which offers integrated quality control and validation, intuitive software, and walk-away convenience for blood banking laboratories. The IH 1000, designed for the blood transfusion laboratory, utilizes the industry accepted gold standard ID-System gel card technology. The instrument has two independent pipetting stations, three centrifuges, and an arm dedicated solely to card transport. There are automated maintenance steps; automatic tube diameter detection and tube decap checks. The machine has a built in integrated back-up system, with pipettors and centrifuges that compensate each other.

John Goetz, Bio-Rad Vice President said, "Our customers who have already worked with the IH 1000 during our testing phase have said the system delivers the highest level of automation as well as improved workflow advantages, without sacrificing the quality of the result."

Related Links:

Bio-Rad Laboratories, Inc



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ESR Analyzer
miniiSED™

Latest Immunology News

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
21 Jul 2010  |   Immunology

Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
21 Jul 2010  |   Immunology

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions
21 Jul 2010  |   Immunology